105 related articles for article (PubMed ID: 31179828)
1. Repeat-Dose Toxicity Study of a Lyophilized Recombinant Protective Antigen-Based Anthrax Vaccine Adjuvanted With CpG 7909.
Savransky V; Lacy M; Ionin B; Skiadopoulos MH; Shearer J
Int J Toxicol; 2019; 38(3):163-172. PubMed ID: 31179828
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the AV7909 Anthrax Vaccine Toxicity in Sprague Dawley Rats Following Three Intramuscular Administrations.
Rao VV; Godin CS; Lacy MJ; Inglefield JR; Park S; Blauth B; Reece JJ; Ionin B; Savransky V
Int J Toxicol; 2021 Oct; 40(5):442-452. PubMed ID: 34281421
[TBL] [Abstract][Full Text] [Related]
3. A CpG-Ficoll Nanoparticle Adjuvant for Anthrax Protective Antigen Enhances Immunogenicity and Provides Single-Immunization Protection against Inhaled Anthrax in Monkeys.
Kachura MA; Hickle C; Kell SA; Sathe A; Calacsan C; Kiwan R; Hall B; Milley R; Ott G; Coffman RL; Kanzler H; Campbell JD
J Immunol; 2016 Jan; 196(1):284-97. PubMed ID: 26608924
[TBL] [Abstract][Full Text] [Related]
4. Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.
Bielinska AU; Janczak KW; Landers JJ; Makidon P; Sower LE; Peterson JW; Baker JR
Infect Immun; 2007 Aug; 75(8):4020-9. PubMed ID: 17502384
[TBL] [Abstract][Full Text] [Related]
5. Nasal immunization with anthrax protective antigen protein adjuvanted with polyriboinosinic-polyribocytidylic acid induced strong mucosal and systemic immunities.
Sloat BR; Cui Z
Pharm Res; 2006 Jun; 23(6):1217-26. PubMed ID: 16718616
[TBL] [Abstract][Full Text] [Related]
6. Marked enhancement of the immune response to BioThrax® (Anthrax Vaccine Adsorbed) by the TLR9 agonist CPG 7909 in healthy volunteers.
Rynkiewicz D; Rathkopf M; Sim I; Waytes AT; Hopkins RJ; Giri L; DeMuria D; Ransom J; Quinn J; Nabors GS; Nielsen CJ
Vaccine; 2011 Aug; 29(37):6313-20. PubMed ID: 21624418
[TBL] [Abstract][Full Text] [Related]
7. Increased long-term immunity to Bacillus anthracis protective antigen in mice immunized with a CIA06B-adjuvanted anthrax vaccine.
Wui SR; Han JE; Kim YH; Rhie GE; Lee NG
Arch Pharm Res; 2013 Apr; 36(4):464-71. PubMed ID: 23440578
[TBL] [Abstract][Full Text] [Related]
8. Safety, reactogenicity and immunogenicity of a recombinant protective antigen anthrax vaccine given to healthy adults.
Campbell JD; Clement KH; Wasserman SS; Donegan S; Chrisley L; Kotloff KL
Hum Vaccin; 2007; 3(5):205-11. PubMed ID: 17881903
[TBL] [Abstract][Full Text] [Related]
9. Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen.
Boyaka PN; Tafaro A; Fischer R; Leppla SH; Fujihashi K; McGhee JR
J Immunol; 2003 Jun; 170(11):5636-43. PubMed ID: 12759444
[TBL] [Abstract][Full Text] [Related]
10. Microneedle-based intradermal delivery of the anthrax recombinant protective antigen vaccine.
Mikszta JA; Dekker JP; Harvey NG; Dean CH; Brittingham JM; Huang J; Sullivan VJ; Dyas B; Roy CJ; Ulrich RG
Infect Immun; 2006 Dec; 74(12):6806-10. PubMed ID: 17030580
[TBL] [Abstract][Full Text] [Related]
11. Intranasal administration of dry powder anthrax vaccine provides protection against lethal aerosol spore challenge.
Huang J; Mikszta JA; Ferriter MS; Jiang G; Harvey NG; Dyas B; Roy CJ; Ulrich RG; Sullivan VJ
Hum Vaccin; 2007; 3(3):90-3. PubMed ID: 17375001
[TBL] [Abstract][Full Text] [Related]
12. Epitope-focused peptide immunogens in human use adjuvants protect rabbits from experimental inhalation anthrax.
Oscherwitz J; Feldman D; Yu F; Cease KB
Vaccine; 2015 Jan; 33(3):430-6. PubMed ID: 25454087
[TBL] [Abstract][Full Text] [Related]
13. A combination of the TLR4 agonist CIA05 and alum promotes the immune responses to Bacillus anthracis protective antigen in mice.
Wui SR; Kim HK; Han JE; Kim JM; Kim YH; Chun JH; Cho YJ; Lee NG
Int Immunopharmacol; 2011 Sep; 11(9):1195-204. PubMed ID: 21492746
[TBL] [Abstract][Full Text] [Related]
14. Repeat Dose Toxicity Study of the AV7909 Anthrax Vaccine Candidate in Juvenile Rats.
Zmarowski A; Ballin JD; Sharits J; Carrico K; Novak J; Shearer J; Blauth B; Ionin B; Reece J; Savransky V
Int J Toxicol; 2020 Jul; ():1091581820941412. PubMed ID: 32691648
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: a randomized, double-blinded, controlled, multicenter trial.
Gorse GJ; Keitel W; Keyserling H; Taylor DN; Lock M; Alves K; Kenner J; Deans L; Gurwith M
Vaccine; 2006 Aug; 24(33-34):5950-9. PubMed ID: 16797805
[TBL] [Abstract][Full Text] [Related]
16. Comparative immunogenicity and efficacy of thermostable (lyophilized) and liquid formulation of anthrax vaccine candidate AV7909.
Autumn Smiley M; Sanford DC; Triplett CA; Callahan D; Frolov V; Look J; Ruiz C; Reece JJ; Miles A; Ruiz E; Ionin B; Shearer JD; Savransky V
Vaccine; 2019 Oct; 37(43):6356-6361. PubMed ID: 31530467
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of recombinant protective antigen and efficacy against aerosol challenge with anthrax.
Williamson ED; Hodgson I; Walker NJ; Topping AW; Duchars MG; Mott JM; Estep J; Lebutt C; Flick-Smith HC; Jones HE; Li H; Quinn CP
Infect Immun; 2005 Sep; 73(9):5978-87. PubMed ID: 16113318
[TBL] [Abstract][Full Text] [Related]
18. A plant based protective antigen [PA(dIV)] vaccine expressed in chloroplasts demonstrates protective immunity in mice against anthrax.
Gorantala J; Grover S; Goel D; Rahi A; Jayadev Magani SK; Chandra S; Bhatnagar R
Vaccine; 2011 Jun; 29(27):4521-33. PubMed ID: 21504775
[TBL] [Abstract][Full Text] [Related]
19. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits.
Wimer-Mackin S; Hinchcliffe M; Petrie CR; Warwood SJ; Tino WT; Williams MS; Stenz JP; Cheff A; Richardson C
Vaccine; 2006 May; 24(18):3953-63. PubMed ID: 16530302
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of non-toxic deletion mutants of protective antigen from Bacillus anthracis.
Rhie GE; Park YM; Han JS; Yu JY; Seong WK; Oh HB
FEMS Immunol Med Microbiol; 2005 Aug; 45(2):341-7. PubMed ID: 16019195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]